CLINICAL TRIALS PROFILE FOR METHOXSALEN
✉ Email this page to a colleague
All Clinical Trials for METHOXSALEN
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00002011 ↗ | The Therakos UVAR Photopheresis System in the Treatment of AIDS-Related Complex | Completed | Mallinckrodt | N/A | 1969-12-31 | To determine the safety and patient tolerance of UVAR Photopheresis System (extracorporeal photopheresis) in the Treatment of AIDS-Related Complex (ARC). |
| NCT00004359 ↗ | Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita | Completed | Northwestern University | Phase 2 | 1996-02-01 | OBJECTIVES: I. Evaluate immunomodulation with extracorporeal photochemotherapy (ECP) in patients with epidermolysis bullosa acquisita. II. Investigate the effect of ECP on lymphocyte activity. |
| NCT00004359 ↗ | Phase II Pilot Study of Extracorporeal Phototherapy for Epidermolysis Bullosa Acquisita | Completed | National Center for Research Resources (NCRR) | Phase 2 | 1996-02-01 | OBJECTIVES: I. Evaluate immunomodulation with extracorporeal photochemotherapy (ECP) in patients with epidermolysis bullosa acquisita. II. Investigate the effect of ECP on lymphocyte activity. |
| NCT00005092 ↗ | Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer | Completed | National Cancer Institute (NCI) | Phase 1 | 1999-05-28 | RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by the chemotherapy or radiation therapy used to kill tumor cells. Sometimes the transplanted cells are rejected by the body's normal tissues. Transplanting donated cells that have been treated with psoralen may prevent this from happening. PURPOSE: Phase I trial to study the effectiveness of chemotherapy, radiation therapy, and psoralen-treated donor cells in treating patients who are undergoing peripheral stem cell transplantation for hematologic cancer. |
| NCT00005092 ↗ | Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer | Completed | M.D. Anderson Cancer Center | Phase 1 | 1999-05-28 | RATIONALE: Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by the chemotherapy or radiation therapy used to kill tumor cells. Sometimes the transplanted cells are rejected by the body's normal tissues. Transplanting donated cells that have been treated with psoralen may prevent this from happening. PURPOSE: Phase I trial to study the effectiveness of chemotherapy, radiation therapy, and psoralen-treated donor cells in treating patients who are undergoing peripheral stem cell transplantation for hematologic cancer. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for METHOXSALEN
Condition Name
Clinical Trial Locations for METHOXSALEN
Trials by Country
Clinical Trial Progress for METHOXSALEN
Clinical Trial Phase
Clinical Trial Sponsors for METHOXSALEN
Sponsor Name
